CN1030453C - Process for producing sodium salt of propyl guluronate sulfuric ester - Google Patents

Process for producing sodium salt of propyl guluronate sulfuric ester Download PDF

Info

Publication number
CN1030453C
CN1030453C CN 88109686 CN88109686A CN1030453C CN 1030453 C CN1030453 C CN 1030453C CN 88109686 CN88109686 CN 88109686 CN 88109686 A CN88109686 A CN 88109686A CN 1030453 C CN1030453 C CN 1030453C
Authority
CN
China
Prior art keywords
ester
guluronic acid
propyl
sodium salt
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 88109686
Other languages
Chinese (zh)
Other versions
CN1042360A (en
Inventor
管华诗
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ocean University of Oingdao
Original Assignee
Ocean University of Oingdao
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ocean University of Oingdao filed Critical Ocean University of Oingdao
Priority to CN 88109686 priority Critical patent/CN1030453C/en
Publication of CN1042360A publication Critical patent/CN1042360A/en
Application granted granted Critical
Publication of CN1030453C publication Critical patent/CN1030453C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a technique for preparing sodium salt of propyl-ester sulfuric ester of guluronic acid, which has the technical scheme that sodium alginate is used as a basic material, and guluronic acid is firstly prepared by steps of acidic hydrolysis, etc., and then, the guluronic acid and the propylene oxide are reacted into guluronic-acid propyl ester through esterification; then, the sodium salt of propyl-ester sulfuric ester of guluronic acid is obtained after sulfonation transformation of chlorosulfuric acid. The sodium salt of propyl-ester sulfuric ester of guluronic acid is a new substance and is also a new heparitin medicine which has no toxin and has the functions of decelerating the growth speed of urine rock salt crystals and preventing crystal accumulation; the sodium salt of propyl-ester sulfuric ester of guluronic acid is particularly suitable for patients with recurrent relapsing calcium calculus of urinary calculus and patients after in-vivo calculus breaking operations.

Description

Process for producing sodium salt of propyl guluronate sulfuric ester
The invention belongs to a kind of preparation technology of heparinoid drug.
In recent years, extracorporeal shock-wave lithotomy disease is got carrying out of new technologies such as stone through perverse the wearing of skin, just changing the appearance of urinary calculus clinical treatment, but the elimination of retained calculus and prevent that recurrence of hepatolithiasis etc. is still two hang-ups that clinical urinary calculus treatment is faced also is the problem that solution is concerned about and is pressed for to present pharmacy, medical circle.
Purpose of the present invention just provides a kind of medicine that can eliminate above-mentioned retained calculus and prevent recurrence of hepatolithiasis, i.e. guluronic acid propyl ester sulfuric ester sodium salt (hereinafter to be referred as ancient sugar ester).Known to the inventor, this is a kind of novel substance, and it does not appear in the newspapers especially as the lithangiuria prophylactic agent.It belongs to a kind of polyanion electrolyte, is a kind of heparinoid drug.
A kind of technology of producing guluronic acid propyl ester sulfuric ester sodium salt is disclosed in the present invention.The basic raw material sodium alginate source of producing said medicine by this technology is wide, and this medicine is nontoxic, has the ability that suppresses lithangiuria, is the calculous good medicine of a kind of control.
Because said medicine is not seen before, so its preparation method also is to propose first.
The raw material of producing the gulose ester is a sodium alginate.Known alginic acid molecule is β-D-(1 → 4) the mannopyranose aldehydic acid unit and α-L-(1 → 4 that connect) the unitary linear copolymers of ancient sieve pyranose aldehydic acid that is connected, i.e. M section and G section.They are to replace block by the M-G that accounts for main component to link together.Therefore it is a straight line block compound.
The technological process of producing ancient sugar ester is as follows:
1, produces guluronic acid
Get quantitative food grade sodium alginate, add gauge water and carry out swelling (swelling time is 1~3 day), then add certain density oxalic acid or hydrochloric acid soln with volume, boiling water bath refluxed 6~12 hours, be hydrolyzed, and after-filtration was removed the supernatant liquor sour water.To filter gains with gauge water towards rare, add the solid Na be equivalent to filtrate weight 0.5~1.0% 2CO 3, make it transfer sodium salt to and form colloidal solution, transfer pH to 2~3 with hydrochloric acid again.Quiet heavy, take out supernatant liquor, again with the throw out centrifugation, centrifugate and supernatant liquor lump together, otherwise processed.Centrifugal centrifugate is added alcohol precipitate, promptly get guluronic acid.
2, produce the guluronic acid propyl ester
The above-mentioned guluronic acid airing that makes to containing a certain amount of moisture content, is joined in the retort that fills quantitative propylene oxide in advance, add quantitative NaOH or KOH or sodium ethylate and make catalyzer, at constant temperature (50~80 ℃), level pressure (1.5~3kg/cm 2) act on 2~4 hours down or adopt normal pressure (temperature is 40~55 ℃) circumfluence method to carry out esterification, promptly get the guluronic acid propyl ester.
3, produce guluronic acid propyl ester sulfuric ester sodium salt
With the above-mentioned guluronic acid propyl ester that makes, with methyl alcohol or ethanol repetitive scrubbing, purification, oven dry then, sulfonation under the Yu Zhongwen.Sulphonating agent adopts chlorsulfonic acid, and solvent can be with methane amide or N, N=methylformamide or pyridine etc.The sulfonation products therefrom is a guluronic acid propyl ester sulfuric ester, is purified again, and, promptly is converted into sodium salt with the NaOH neutralization, and be exactly guluronic acid propyl ester sulfuric ester sodium salt, also be ancient sugar ester.
Embodiment
1. get food grade sodium alginate 100 grams, add 5000 ml distilled water swellings 24 hours, add 5000 milliliters of 2N oxalic acid again, boiling water bath refluxed 10 hours, filtered, and removed acid solution.Add 3000ml distilled water to filtrate, make its dissolving, and then add solid Na in the ratio of 100 gram solids, 1 gram 2CO 3, making it transfer sodium salt to and become colloidal state, this colloid transfers pH to make it arrive pH=2.85 with 4N HCL, sedimentation, precipitation is got its centrifugal sediment with 3000 rev/mins whizzer centrifugation, add ethanol sedimentation and dewater, and airing to water content reaches 40%.Promptly get the guluronic acid raw product.
2. with 100 gram guluronic acids of above-mentioned water content 40%, add the 300ml propylene oxide in autoclave, add 0.6 gram NaOH again at 1.5Kg/cm 2Pressure under, 65 ℃ of temperature effect 2 hours, its propyl ester, behind methyl alcohol repetitive scrubbing three times,, promptly get guluronic acid propyl ester dry product in 60 ℃ of oven dry.
3. get guluronic acid propyl ester 100 grams of above-mentioned oven dry, place the 3000ml there-necked flask, add the 1000ml methane amide again, stirring is mixed, slowly drip the 300ml chlorsulfonic acid, temperature is not higher than 5 ℃ in the dropping process, after dripping, makes it be warming up to 65~70 ℃, reacted 3 hours, cooling is filtered, and adds medicinal ethanol sedimentation, the throw out dissolved in distilled water, use ethanol sedimentation again, three times so repeatedly, again after the dissolving, transform with 4N NaOH, use 732,717 cationic, anionic exchange resin desalinations again, alcohol precipitation is used in the back, promptly gets guluronic acid propyl ester sulfuric ester sodium salt.
The ancient sugar ester of being produced among the present invention, its raw material sources are wide, are convenient to mass production, the no three wastes, output and steady quality.It can slow down urinary calculi salt crystalline growth velocity the pharmacological testing proof, prevents the crystalline gathering, and urinary tract mucosa or epithelium are had provide protection.This product is nontoxic, does not have the effect of paying, and irritates stomach with 18~22 gram TWOs and carries out toxicity research, and dosage reaches 5g/kg, and animal subject does not have any toxic reaction.Therefore it is very suitable for recurrent calcic calculus patient that urinary calculi shows effect repeatedly and through the postoperative patient of inside and outside rubble, to eliminate retained calculus and to prevent recurrence of hepatolithiasis, promptly the invention provides a kind of good lithangiuria inhibitor.

Claims (1)

1, a kind ofly produces the technology of guluronic acid propyl ester sulfuric ester sodium salt, it is characterized in that earlier with sodium alginate hydrolysis, separation esterification then, sulfonation again by sodium alginate; Described hydrolysis, be separated under the acidic conditions and carry out, and need boiling water bath to reflux 6~12 hours; Described esterification is meant the guluronic acid that made by hydrolysis and the reaction of propylene oxide, and this is reflected at temperature is 50~80 ℃, pressure 1.5~3kg/cm 2Carry out under the condition, also can adopt the atmospheric pressure reflux method under 40~55 ℃, to carry out, and be catalyzer with NaOH or KoH or sodium ethylate; The guluronic acid propyl ester that makes in the middle of described sulfonation is meant and the reaction of chlorsulfonic acid, wherein solvent is methane amide or pyridine, sulfonation is carried out under 60~80 ℃ of conditions.
CN 88109686 1988-10-30 1988-10-30 Process for producing sodium salt of propyl guluronate sulfuric ester Expired - Fee Related CN1030453C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 88109686 CN1030453C (en) 1988-10-30 1988-10-30 Process for producing sodium salt of propyl guluronate sulfuric ester

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 88109686 CN1030453C (en) 1988-10-30 1988-10-30 Process for producing sodium salt of propyl guluronate sulfuric ester

Publications (2)

Publication Number Publication Date
CN1042360A CN1042360A (en) 1990-05-23
CN1030453C true CN1030453C (en) 1995-12-06

Family

ID=4835413

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 88109686 Expired - Fee Related CN1030453C (en) 1988-10-30 1988-10-30 Process for producing sodium salt of propyl guluronate sulfuric ester

Country Status (1)

Country Link
CN (1) CN1030453C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109200058B (en) * 2017-07-03 2020-09-04 青岛海洋生物医药研究院股份有限公司 Application of poly (propyl guluronate) sulfate in preparation of anticoagulant drugs

Also Published As

Publication number Publication date
CN1042360A (en) 1990-05-23

Similar Documents

Publication Publication Date Title
JP3403496B2 (en) Anti-ulcer agent and Helicobacter pylori colonization inhibitor
AU2008206969B2 (en) Iron-carbohydrate complex compounds
JPH04503813A (en) Drugs, food products and compositions that inhibit cholesterol absorption
JPS62201901A (en) Beta-d-glucan and its production and use
JPH0741505A (en) Antiviral substance
CN107325205A (en) A kind of inulin and FOS syrup co-production
EP0315113A2 (en) Inner esters of gangliosides with analgesic-antiinflammatory activity
JP2681653B2 (en) Anti-AIDS virus agent
CN1796395A (en) Method for preparing N - acetyl - D - glucosamine (NAG)
JP2806522B2 (en) Method for producing branched fructooligosaccharide
CN1030453C (en) Process for producing sodium salt of propyl guluronate sulfuric ester
KR20000036774A (en) Preparing Methode for Aqueous Chitosan
CN1030454C (en) Production of sodium salt of propyl mannuronate sulfuric ester
CN1087610C (en) Lentinus edodes polysaccharide injecta and its preparation
CN1089619A (en) A kind of production method of propylene glycol alginate sodium sulfate
JPH0648950A (en) Antiulcer agent
JP2021159064A (en) Konjac powder multienzyme hydrolysate and preparation method thereof
AU648556B2 (en) Therapeutic composition containing hydrolysed carboxyalkyl cellulose
KR20010054390A (en) The processing method of chito oligosaccharides using enzyme
CN1027590C (en) Production method for extracting low-ester pectin from sunflower disc
JP2766439B2 (en) Cholesterol suppressant
CN112608958B (en) Chitosan oligosaccharide preparation method and weight-losing tablets
CN1120725C (en) Medicine for treating osteoporosis and hyperosteogeny and preparation process thereof
CN1042474A (en) Pectin plasma substitute and preparation method
EP1043022B1 (en) Sodium ion absorption inhibitors and sodium ion excretion accelerators as preventive and therapeutic agents for diseases resulting from excessive intake of common salt

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee